Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 9/20 | 0.46 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29532989 | 1.00 | FDPS (0.46) | FDPSGGPS1LMNATSHRALDH1A1 | |
| SCHEMBL30510647 | 1.00 | FDPS (0.46) | FDPSGGPS1LMNATSHRALDH1A1 | |
| SCHEMBL30532496 | 1.00 | FDPS (0.46) | FDPSGGPS1LMNATSHRALDH1A1 | |
| SCHEMBL4204835 | 1.00 | FDPS (0.46) | FDPSGGPS1LMNATSHRALDH1A1 | |
| SCHEMBL30510634 | 1.00 | FDPS (0.46) | FDPSGGPS1LMNATSHRALDH1A1 | |
| SCHEMBL28668491 | 1.00 | FDPS (0.46) | FDPSGGPS1LMNATSHRALDH1A1 | |
| SCHEMBL28718184 | 1.00 | FDPS (0.46) | FDPSGGPS1LMNATSHRALDH1A1 | |
| SCHEMBL4204709 | 1.00 | FDPS (0.46) | FDPSGGPS1LMNATSHRALDH1A1 | |
| SCHEMBL4294187 | 1.00 | FDPS (0.46) | FDPSGGPS1LMNATSHRALDH1A1 | |
| SCHEMBL303129 | 1.00 | FDPS (0.46) | FDPSGGPS1LMNATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250144269-A1 | A protein composition having a joint repair function and its preparation method and application | BEIJING DARWIN BIOTECH CO., LTD. (CN) | 2025-05-08 | — | — | US | claimed |
| CN-116829203-A | Coated medical product | 亨莫特克股份公司 | 2023-09-29 | — | — | CN | claimed |
| CN-116710156-A | Coated medical product | 亨莫特克股份公司 | 2023-09-05 | — | — | CN | claimed |
| US-20250144269-A1 | A protein composition having a joint repair function and its preparation method and application | BEIJING DARWIN BIOTECH CO., LTD. (CN) | 2025-05-08 | — | — | US | disclosed |
| CN-117715537-A | Bio-based biodegradable compositions and articles made therefrom | 罗利制品有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-116829203-A | Coated medical product | 亨莫特克股份公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-116710156-A | Coated medical product | 亨莫特克股份公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-109475491-B | Palpable marker compositions | 丹麦技术大学 | 2022-06-24 | — | — | CN | disclosed |
| US-20200172859-A1 | CYANOBACTERIA HAVING IMPROVED PHOTOSYNTHETIC ACTIVITY | Lumen Bioscience, Inc. | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250144269-A1 | A protein composition having a joint repair function and its preparation method and application | MMP13, DNASE1, XRCC5 | FDPS 3616/4885GGPS1 3894/4885LMNA 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.